The Breast Cancer Research Foundation Medical Symposium held at The Breakers Hotel, Palm Beach, FL on Monday, February 7, 2012
Symposium Topic:
"How science is revolutionizing our approach to breast cancer"
Symposium Opening:
Leonard A. Lauder, Acting Chairman, BCRF
Welcome:
Myra Biblowit, President, BCRF
Welcome and Introduction of Panelists
Clifford Hudis, MD, Moderator Chief, Breast Cancer Medicine Service and Attending Physician
Memorial Sloan-Kettering Cancer Center
Introduction:
Larry Norton, MD, BCRF Scientific Director - Panelist
Deputy Physician-in-Chief, Director of Breast Cancer Programs
Memorial Sloan-Kettering Cancer Center
Introduction:
Edith A. Perez, MD - Panelist
Deputy Director, Mayo Clinic Cancer Center, Jacksonville, FL
Introduction:
Daniel A. Haber, MD, PhD - Panelist
Director, Massachusetts General Hospital Cancer Center, Boston
Q&A - Panel Discussions:
"Can the circulating tumor cell (CTC) chip be used in cancer screening?"
Response by:
Dan Haber, MD, PhD (panelist)
Larry Norton, MD (panelist)
Edith Perez, MD (panelist)
"What is the difference between aromatase inhibitors and tamoxifen?"
Response by:
Edith Perez, MD (panelist)
Clifford Hudis, MD (Moderator)
"How effective is the removal of ovaries or breasts in breast cancer therapy?"
Response by:
Edith Perez, MD (panelist)
Clifford Hudis, MD (Moderator)
"What progress has been made on cancer vaccines?"
Response by:
Jose Baselga, PhD (from the audience)
"Modulating the immune system"
Response by Clifford Hudis, MD (Moderator)
"Is MRI a useful addition to screening for a person with no family history, no children?"
Response by:
Clifford Hudis, MD (Moderator)
"What about male breast cancer?"
Response by:
Dan Haber, MD, PhD (panelist)
Clifford Hudis, MD (Moderator)
Closing Remarks:
Clifford Hudis, MD (moderator)
|
